Congress funds cancer screening for underserved women, targeting racial disparities.

What it does

This bill authorizes $20 million annually (2027–2029) in federal grants to women's health providers—particularly Planned Parenthood and community health centers—to expand cancer screening services (breast, cervical, ovarian, and other gynecologic cancers) for low-income women and women of color. It also funds provider training on cancer screening best practices and implicit bias, and establishes a demonstration project testing co-testing models for cervical cancer. The bill aims to reduce cancer mortality disparities and improve early detection in underserved populations.

Why we flagged it

The bill's operative mechanism is straightforward: federal grant funding to expand cancer screening access in underserved populations. It is not a tax carve-out, deregulation, or narrow industry subsidy—it is a targeted public health appropriation addressing documented disparities.

What the text implies

• The bill names Planned Parenthood and family planning entities as eligible grant recipients without naming them explicitly, but section 317P–2(c)(2) defines 'essential community provider' entities 'primarily engaged in family planning' as eligible—this will likely direct significant federal funding to Planned Parenthood, which may trigger political controversy despite the public health rationale.
• The study and reporting requirement (section 6) mandates analysis of 'how structural racism impacts access to cancer screening' and outcomes by race/ethnicity—this frames cancer disparities as a systemic equity issue, which may influence future policy but does not itself change law.
• The demonstration project on HPV/cervical cancer co-testing (section 317P–3) is time-limited (2 years) and requires evaluation before expansion, creating a pathway for future federal investment if results support broader rollout.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill directly funds expanded access to preventive cancer screening for low-income women and women of color, populations with documented higher mortality rates from breast and gynecologic cancers. It also invests in provider training on evidence-based screening and cultural competency, addressing structural barriers to care.

Who stands to gain

• federally qualified health centers
• nonprofit family planning providers
• community health centers
• entities receiving HRSA funding

Named in the bill

Secretary of Health and Human Services, Centers for Disease Control and Prevention, Health Resources and Services Administration, Planned Parenthood (implied as eligible entity), National Breast and Cervical Cancer Early Detection Program, U.S. Preventive Services Task Force

Where it stands

15 cosponsors: 15 Democrats.

• Sep 24, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Sep 24, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.